Mubadala, CBC Group to buy UCB's Chinese neurology and allergy business for $680m

Mubadala, CBC Group to buy UCB's Chinese neurology and allergy business for $680m

Photo by Raimond Klavins on Unsplash

Stephanie Li

26 August, 2024

Edited by: Pramod Mathew

CBC GroupMubadala Investment CompanyUCB Pharma

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.